Pricing Log in Create free account
Friday 6 November 2026 Export MDLN’s income statement to Excel — free account

Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue
+14.1%
Free cash flow
+916.1%
Total debt
−23.7%

Quarter to September 2026, against a year earlier

39.96 0.39 −0.97%
Market cap
$52.3B
P/E
58.4×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.25
Beneish M
−2.38
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Medline Inc. (MDLN) EBITDA

Alert me on EBITDA

Medline Inc.'s EBITDA for fiscal 2025 was $3.3B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $10.0B. Medline Inc. ranks 1st of 47 Medical Instruments & Supplies companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $3.3B 2.40%
FY2024 $3.2B 35.18%
FY2023 $2.4B —

Quarterly newest first

Period EBITDA Change
Jun 2026 $664.0M (3.35%)
Mar 2026 $687.0M (91.18%)
Dec 2025 $7.8B 758.54%
Jun 2025 $907.0M 8.88%
1 more quarters

EBITDA against peers

Company EBITDA
MDLN Medline Inc. $10.0B
BDX Becton, Dickinson and Company compare $4.8B
ISRG Intuitive Surgical, Inc. compare $4.1B
ALC Alcon compare $2.7B
SOLV Solventum Corporation compare $2.6B
RMD ResMed Inc. compare $2.1B
BAX Baxter International Inc. compare $1.5B
WST West Pharmaceutical Services, Inc. compare $964.5M
COO The Cooper Companies, Inc. compare $928.2M

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on MDLN